Who
Charles O. Williams
Chief Operating Officer
Company insider
Files Form 4 as: Chief Operating Officer, Surrozen.
In numbers
- Trades disclosed
- 56
- Buys
- 1
- Sells
- 3
- Bought
- $0
- Sold
- $218K
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 12 Aug 2021
- Last trade
- 15 Jun 2026
- Last filed
- 16 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 15 Jun 2026filed 16 Jun 2026 | SRZN SurrozenBiotechnology | SEC FORM 4 Code A | $14K1,666 at $8.11 | filing |
| 15 Jun 2026filed 16 Jun 2026 | SRZN SurrozenBiotechnology | SEC FORM 4 Code A | $14K1,666 at $8.11 | filing |
| 4 May 2026filed 5 May 2026 | SRZN SurrozenBiotechnology | SEC FORM 4 Sold | $68K2,036 at $33.33 | filing |
| 4 May 2026filed 5 May 2026 | SRZN SurrozenBiotechnology | SEC FORM 4 Sold | $68K2,036 at $33.33 | filing |
| 1 May 2026filed 5 May 2026 | SRZN SurrozenBiotechnology | SEC FORM 4 Code M | —5,625 | filing |
| 1 May 2026filed 5 May 2026 | SRZN Surrozenoption or derivative · Biotechnology | SEC FORM 4 Code M | —5,625 at $0.00 | filing |
| 1 May 2026filed 5 May 2026 | SRZN Surrozenoption or derivative · Biotechnology | SEC FORM 4 Code M | —5,625 at $0.00 | filing |
| 1 May 2026filed 5 May 2026 | SRZN SurrozenBiotechnology | SEC FORM 4 Code M | —5,625 | filing |
| 17 Feb 2026filed 18 Feb 2026 | SRZN Surrozenoption or derivative · Biotechnology | SEC FORM 4 Code A | —102,900 at $0.00 | filing |
| 17 Feb 2026filed 18 Feb 2026 | SRZN Surrozenoption or derivative · Biotechnology | SEC FORM 4 Code A | —102,900 at $0.00 | filing |
| 17 Feb 2026filed 18 Feb 2026 | SRZN Surrozenoption or derivative · Biotechnology | SEC FORM 4 Code A | —102,900 at $0.00 | filing |
| 17 Feb 2026filed 18 Feb 2026 | SRZN Surrozenoption or derivative · Biotechnology | SEC FORM 4 Code A | —102,900 at $0.00 | filing |
| 23 Jan 2026filed 26 Jan 2026 | SRZN Surrozenoption or derivative · Biotechnology | SEC FORM 4 Code A | —500 at $0.00 | filing |
| 23 Jan 2026filed 26 Jan 2026 | SRZN Surrozenoption or derivative · Biotechnology | SEC FORM 4 Code A | —500 at $0.00 | filing |
| 5 Jan 2026filed 6 Jan 2026 | SRZN SurrozenBiotechnology | SEC FORM 4 Sold | $31K1,566 at $19.87 | filing |
| 5 Jan 2026filed 6 Jan 2026 | SRZN SurrozenBiotechnology | SEC FORM 4 Sold | $31K1,566 at $19.87 | filing |
| 2 Jan 2026filed 6 Jan 2026 | SRZN SurrozenBiotechnology | SEC FORM 4 Code M | —3,500 | filing |
| 2 Jan 2026filed 6 Jan 2026 | SRZN Surrozenoption or derivative · Biotechnology | SEC FORM 4 Code M | —3,500 at $0.00 | filing |
| 2 Jan 2026filed 6 Jan 2026 | SRZN Surrozenoption or derivative · Biotechnology | SEC FORM 4 Code M | —3,500 at $0.00 | filing |
| 2 Jan 2026filed 6 Jan 2026 | SRZN SurrozenBiotechnology | SEC FORM 4 Code M | —3,500 | filing |
News
Head to Head Review: Surrozen (NASDAQ:SRZN) vs. AbCellera Biologics (NASDAQ:ABCL)SRZN · tickerreport.com · 14 Oct 2026Surrozen Sees Unusually Large Options Volume (NASDAQ:SRZN)SRZN · themarketsdaily.com · 12 Oct 2026Head to Head Analysis: Whitehawk Therapeutics (NASDAQ:WHWK) vs. Surrozen (NASDAQ:SRZN)SRZN · dailypolitical.com · 10 Oct 2026
0 headlines in the last 90 days name Charles O. Williams; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.